GALD - Galderma Group N - Stock Price & Dividends

Galderma Group AG is a dermatology company that operates globally, offering a diverse range of science-backed brands and services that cater to the entire dermatology market.

The company's portfolio is divided into three main categories: injectable aesthetics, dermatological skincare, and therapeutic dermatology. In injectable aesthetics, Galderma's flagship brands include Dysport/Azzalure, Alluzience, Restylane, and Sculptra, which are used for various cosmetic procedures such as facial rejuvenation and wrinkle treatment.

In dermatological skincare, the company's prominent brands are Cetaphil and Alastin, which provide a range of products for skin health and beauty. These products are designed to address various skin concerns, including acne, aging, and hyperpigmentation.

In therapeutic dermatology, Galderma's portfolio consists of a wide range of brands, including Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl. These brands offer treatments for various skin conditions, such as acne, rosacea, psoriasis, and skin cancer.

Founded in 1981, Galderma Group AG is headquartered in Zug, Switzerland, and has established itself as a leader in the dermatology industry. The company's commitment to science-based innovation has enabled it to develop a comprehensive range of products and services that cater to the diverse needs of dermatologists, healthcare professionals, and patients worldwide.

For more information, please visit Galderma's website at https://www.galderma.com.